Paper14746554
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.
Merlini G and 1 other. J Intern Med, 2004. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. Papers, record 14746554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14746554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloid | Major topic |
| Amyloidosis | Major topic |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| E.0793 | Telethon | Italy | PubMed |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42809190 | Unraveling cardiac amyloidosis in Egypt: diagnostic challenges and disease outcomes. | Egypt Heart J | 2026 | https://conductscience.org/library/papers/42809190 | PubMed |
| 41659097 | Bridging the Gap in AL and ATTR Cardiac Amyloidosis: Integrating Histopathology, Biomarkers, and Multimodal Imaging for Subtype-Specific Diagnosis. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/41659097 | PubMed |
| 41059241 | Primary Localized Conjunctival Amyloidosis Mimicking Lymphoma. | Beyoglu Eye J | 2025 | https://conductscience.org/library/papers/41059241 | PubMed |
| 40985278 | Central nervous system involvement in cardiac amyloidosis: Redefining the heart-brain axis. | Eur J Clin Invest | 2026 | https://conductscience.org/library/papers/40985278 | PubMed |
| 40142821 | Transthyretin Amyloid Cardiomyopathy: Current Diagnostic Approach and Risk Stratification with Multimodality Imaging. | J Clin Med | 2025 | https://conductscience.org/library/papers/40142821 | PubMed |
| 40093801 | Knowledge Landscape and Hotspots of Research in Transthyretin Amyloid Cardiomyopathy: A Bibliometric Analysis. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/40093801 | PubMed |
| 39857067 | A Narrative Review of Biomarkers and Imaging in the Diagnosis of Acute Aortic Syndrome. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/39857067 | PubMed |
| 37381778 | Amyloidogenic light chains impair plasma cell survival. | Haematologica | 2023 | https://conductscience.org/library/papers/37381778 | PubMed |
| 36341129 | Multidisciplinary amyloidosis care in the era of personalized medicine. | Front Neurol | 2022 | https://conductscience.org/library/papers/36341129 | PubMed |
| 36217437 | Contrasting presentations of the same disease: A comparison of two cases of amyloidosis presenting with eyelid involvement. | Am J Ophthalmol Case Rep | 2022 | https://conductscience.org/library/papers/36217437 | PubMed |
| 35524881 | Imaging-Guided Treatment for Cardiac Amyloidosis. | Curr Cardiol Rep | 2022 | https://conductscience.org/library/papers/35524881 | PubMed |
| 34641582 | Common Factors of Alzheimer's Disease and Rheumatoid Arthritis-Pathomechanism and Treatment. | Molecules | 2021 | https://conductscience.org/library/papers/34641582 | PubMed |
| 34129344 | Cardiac Amyloidosis: Multimodal Imaging of Disease Activity and Response to Treatment. | Circ Cardiovasc Imaging | 2021 | https://conductscience.org/library/papers/34129344 | PubMed |
| 33693246 | Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis. | Circ Rep | 2020 | https://conductscience.org/library/papers/33693246 | PubMed |
| 32735824 | Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease. | Stem Cell Reports | 2020 | https://conductscience.org/library/papers/32735824 | PubMed |
| 32042139 | Diagnostic imaging of cardiac amyloidosis. | Nat Rev Cardiol | 2020 | https://conductscience.org/library/papers/32042139 | PubMed |
| 31993048 | Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses. | Front Immunol | 2019 | https://conductscience.org/library/papers/31993048 | PubMed |
| 31452023 | Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis. | Clin Auton Res | 2019 | https://conductscience.org/library/papers/31452023 | PubMed |
| 29700090 | Cardiac amyloidosis. | Clin Med (Lond) | 2018 | https://conductscience.org/library/papers/29700090 | PubMed |
| 29449366 | Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin. | Circ Heart Fail | 2018 | https://conductscience.org/library/papers/29449366 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14746554
GET https://conductscience.org/api/papers/v1/14746554/cited_by?page=2